Boston Innovation Meets ADME Precision

Smarter ADME Screening. Flexible Bundle. Greater Confidence. Flexible Screening Panels That Evolve With Your Pipeline. We get it – early discovery is fast-moving and complex. That’s why our bundled in vitro ADME panels are designed for your workflow, whether you choose one, two, or a full suite. Speed, Clarity, and Tailored Flexibility. and we are […]

Medicilon—Developing PDX-Derived Organoid Models for Efficacy Evaluation of Anticancer Therapies (Download)

PDX-derived organoids combine the genetic fidelity of patient tumors with the scalability and speed of in vitro platforms—delivering a powerful model for evaluating therapeutic response. These models enable:🔷 More accurate efficacy prediction🔷 Reduced translational gaps🔷 Faster iteration for lead optimization This approach strengthens the bridge between preclinical data and clinical outcomes—empowering oncology researchers to make […]

Search Medicilon

【Case Study】New Approach Methods NAMs

Medicilion Congratulates MediLink Therapeutics on Licensing B7H3 ADC to Roche

Medicilion Congratulates MediLink Therapeutics on Licensing B7H3 ADC to Roche

AACR 2026

Contact Medicilon

Name(Required)
Address(Required)